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OBITUARY
Professor Timothy McElwain
It was with great sadness that we heard of the death of Tim
McElwain, Professor of Medical Oncology at the Institute
for Cancer Research and the Royal Marsden Hospital and
one of the leading figures in British medical oncology and
cancer research. He died suddenly on Monday 26 November
1990 at his home in Clapham at the age of 53.
Tim McElwain was a remarkable and unforgettable man
whose achievements were substantial and who has left an
indelible mark upon the development of medical oncology in
the United Kingdom. Almost all of the senior academics in
this field in the United Kingdom either worked with Tim
McElwain or for him at some time in their careers. Medical
Oncologists trained by him have populated the United King-
dom and many other parts of the English speaking world.
A catalogue of his achievements is lengthy and varied.
Born in New Zealand and brought up in Australia, he had a
late start in medicine qualifying from St Bartholomew's with
distinction in 1965 at the age of 28. His success continued at
St Bartholomew's, the Hammersmith, Great Ormond Street
and the Royal Marsden Hospital and he was a Consultant
seven years after qualifying. He remained at the Royal Mars-
den throughout his Consultant career initially as a Senior
Lecturer, then as Consultant Physician and finally as Cancer
Research Campaign Professor in 1983. Throughout his career
he was involved widely in the medical aspects of cancer care
particularly the development of chemotherapy. His early
work in paediatric oncology, germ cell tumours and
leukaemia placed him at the forefront of the development of
the field. His modifications of chemotherapy for Hodgkin's
disease were responsible for the great strides that madetreat-
ment more acceptable and tolerable for patients. Regimens
designed by Tim McElwain remain the standards by which
all others must now be judged. In the late '70's and through-
out the 1980's he explored innovations in cancer
chemotherapy including the use of high dose treatments in
which field he was the first and remained the leading UK
exponent. Substantial improvements in the management of
lymphoma and myeloma were made using the techniques he
pioneered.
He was primarily a clinical academic and his innovations
were driven by his imaginative approach to clinical practice
and his intense caring for his patients but his interests
extended far beyond therapeutic innovation. His common
sense served to keep the feet of British medical oncologists
firmly on the ground at times when some others were lost in
enthusiasm for therapy. His critical and incisive judgement
always revealed the fallacies of over-enthusiastic approaches
to cancer treatments. His concern for improvements in the
quality of life of patient and his careful consultation with
patients before embarking on complex therapies have estab-
lished the standards of practice for those he trained and will
continue in the standards held by the next generation of
British clinical oncologists. His commitment to the support
of his patients in all ways was most clearly illustrated by the
effort he put in to aid the establishment of the patient
support group BACUP, with Vicky Clement Jones in the late
1980's.
Tim McElwain naturally became a leader of his specialty.
He established the Association of Cancer Physicians ofwhich
he was the first Chairman and he either chaired, supported or
significantly influenced all of the committees which govern
the specialty. His influence in the Royal College in recent
years has always been exerted towards more integration and
amalgamation of the rather fragmented specialties of clinical
oncology in the United Kingdom. This surprised many who
had seen him as one of the leading forces developing medical
oncology as a separate specialty. Nevertheless his long-term
view and common sense compelled him to the conclusion
that greater integration had to be achieved despite the
obvious difficulties. He was a member of the United King-
dom Co-ordinating Committee on Cancer Research and a
member of Council at the MRC and his advice was widely
sought formally and informally in this country and abroad.
Such a catalogue of achievements in itself speaks to his
powerful personality. However he was in many ways more
remarkable and memorable than even this long list can sug-
gest. His tremendous physical and personal presence could be
felt whether in the senior committees of the major funding
bodies and governing bodies of oncology in the United King-
dom or in small groups of individuals discussing the subject
in a bar. He was always prepared to lend his common sense,
incisive wisdom and kindness to colleagues or juniors who
needed his help or advice. His ability to recognise the essence
of any matter was perhaps his greatest strength. He painted
his conceptual pictures with a broad brush allowing others to
contribute the details. He was renowned for the fierceness of
his temper but those who knew him well came to recognise
that this was short-lived and invariably followed by kindness.
His interests outside medicine were wide and well served by
an extraordinary memory. No one meeting him could fail to
realise that under his convivial manner lay a huge fund of
knowledge of music, literature, politics and a serious and
unpretentious knowledge of wine. Conversation with Tim
McElwain could be challenging and was never dull not least
because he could be as good a listener as he was a talker.
Tim McElwain, who was often known to friends as Mac,
had great ability and humanity and a grand personality. He
carried a huge workload on behalf of his patients, cancer
research and his friends. The world will be a duller and
poorer place without Mac. We extend our deepest sympathy
to Glennis McElwain and his family.
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